Document is current
Any future updates will be listed below
-
Authors
Perszyk, Riley E. http://orcid.org/0000-0001-8283-7709
Swanger, Sharon A.
Shelley, Chris http://orcid.org/0000-0001-7263-7324
Khatri, Alpa
Fernandez-Cuervo, Gabriela
Epplin, Matthew P. http://orcid.org/0000-0002-1121-3701
Zhang, Jing
Le, Phuong
Bülow, Pernille
Garnier-Amblard, Ethel
Gangireddy, Pavan Kumar Reddy
Bassell, Gary J.
Yuan, Hongjie http://orcid.org/0000-0002-8127-7145
Menaldino, David S.
Liotta, Dennis C.
Liebeskind, Lanny S. http://orcid.org/0000-0002-2223-6618
Traynelis, Stephen F. http://orcid.org/0000-0002-3750-9615
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH109026)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD082373)
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS065371)
- License Information
-
More Information
Article History
Received: 28 December 2018
Revised: 8 November 2019
Accepted: 4 December 2019
First Online: 20 January 2020
Competing interests
: Several authors have competing interests. S.F.T. is a consultant for Janssen Pharmaceuticals, principal investigator on research grants from Janssen and Allergan to Emory University School of Medicine, a member of the scientific advisory board for Sage Therapeutics, the GRIN2B Foundation, and the CureGRIN Foundation, co-founder of NeurOp and receives royalties for software. D.C.L. is a member of the Board of Directors for NeurOp. D.C.L., D.S.M., E.G.A., G.F.C., P.K.R.G., L.S.L., M.P.E., S.F.T. are co-inventors on Emory-owned intellectual property that includes allosteric modulators of NMDA receptor function. H.Y. is principal investigator on a research grant from Sage Therapeutics to Emory University School of Medicine.
